Skip to main content

Table 3 Reinfection and recrudescence rate of Helicobacter pylori

From: Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy

Variable category E B M T group M E A group p-value*
Recrudescence (n = 60) (n = 120)  
  Yes 1 (1.7%) 4 (3.3%) 0.67
  No 59 (98.3%) 116 (96.7%)  
Reinfection (n = 59) (n = 116)  
  Yes 7 (11.9%) 19 (16.4%) 0.43
  No 52 (88.1%) 97 (83.6%)  
  1. EBMT: esomeprazole (20 mg b.i.d), tripotassium dicitrate bismuthate (300 mg q.i.d), metronidazole (500 mg t.i.d), and tetracycline (500 mg q.i.d); MEA: moxifloxacin (400 mg q.d.), esomeprazole (20 mg b.i.d), and amoxicillin (1000 mg b.i.d.).
  2. * P-value for Pearson chi-square test or Fisher’s exact test for comparison of categorical data.